Savannah Doliboa

Savannah Doliboa is an accomplished professional with extensive experience in global business development and commercial strategy within the clinical trial industry. Currently serving as Chief Commercial Officer at CTI Clinical Trial and Consulting Services, Savannah is responsible for the organization's global commercial strategy. Previous roles include Vice President of Global Business Development & Strategic Relationships at CTI, where responsibilities encompassed sales and therapeutic strategy, and Executive Director of North American Business Development and Client Management. Additional experience includes leadership positions at Cytel, Pharm-Olam, and IQVIA, emphasizing business development and territory management for biotech accounts. Savannah holds an Executive MBA from Xavier University and a Bachelor's degree in Biological Sciences from Wright State University.